Intelligent medical diagnosis and computing system faces many challenges in complex object recognition, large-scale data imaging and real-time diagnosis, such as poor real-time computing, low efficiency of data storage and low recognition rate of lesions. In order to solve the above problems, this paper proposes a medical intelligent computing system and a series of algorithms for the clinical pathology of cervical cancer based on the multi-scale imaging and transfer learning framework. Firstly, based on data dimensions, imaging errors and other factors, this paper designs a multi-scale time-sharing elastic imaging algorithm based on image reconstruction time and data sample characteristics. Then, taking the burst imaging cohort and the calculation data set of new cervical cancer cases as the objects, based on the difficulties of cervical cancer feature modeling, this paper proposes the transfer learning algorithm of clinical and pathological features of cervical cancer. Finally, a medical intelligent computing system for cervical cancer pathology analysis and calculation with high efficiency and reliability is established. A series of proposed algorithms are compared with single-scale Retinex (SSR), which is based on single-scale Retinex migration learning (SSR-TL). The experimental results show that the proposed algorithm in cervical cancer pathological imaging and scoring, as well as the feature extraction and recognition of lesions, especially the efficiency of system execution, is obviously due to the comparison algorithm.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10916-019-1433-zDOI Listing

Publication Analysis

Top Keywords

cervical cancer
28
computing system
16
transfer learning
12
medical intelligent
12
intelligent computing
12
paper proposes
8
single-scale retinex
8
cervical
7
cancer
7
imaging
6

Similar Publications

Rare cancer survivorship research funding at the National Institutes of Health (NIH), 2017 to 2023.

Cancer Causes Control

January 2025

Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Purpose: Rare cancers are defined as those for which there are less than 15 cases per 100,000 in the population annually. While much progress in detection and treatment has been made over the past decade for many rare cancers, less progress has been made in understanding survivorship needs. The objective of this study was to characterize the National Institutes of Health (NIH) cancer survivorship grant portfolio focused on rare cancers and to identify gaps specific to this area of science.

View Article and Find Full Text PDF

Background: Cisgender women living with HIV (WLWH) are disproportionately impacted by cervical cancer. Nevertheless, disparities in uptake and implementation of cervical cancer services persist in sub-Saharan Africa, where population-level estimates of screening coverage remain scarce.

Methods: We pooled data from nationally representative Population-based HIV Impact Assessment (PHIA) surveys conducted in Ethiopia, Malawi, Rwanda, Tanzania, Zambia, and Zimbabwe (2015-2019).

View Article and Find Full Text PDF

Cancer is a major global concern. Despite considerable advancements in cancer therapy and control, there are still large gaps and requirements for development. In recent years, various naturally occurring anticancer drugs have been derived from natural resources, such as alkaloids, glycosides, terpenes, terpenoids, flavones, and polyphenols.

View Article and Find Full Text PDF

Clear cell adenocarcinoma of the cervix (CCAC) is a rare subtype of cervical adenocarcinoma. It has been linked to intrauterine exposure to diethylstilbestrol (DES) but can happen in non-DES-exposed patients, albeit less commonly. Presentation is largely vaginal bleeding, emphasizing the importance of considering CCAC in the differential of abnormal vaginal bleeding despite the tumor's rarity.

View Article and Find Full Text PDF

Introduction Human papillomavirus (HPV) is a well-documented cause of cervical cancer, leading to significant mortality that may be decreased through screening and the administration of HPV vaccination. Our understanding of New Zealand immigrants' knowledge, attitudes, and perceptions of the HPV vaccine is limited. Preliminary research shows that immigrants have low knowledge and negative perceptions of the HPV vaccine and that cervical cancer and HPV awareness was low among African parents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!